Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions

NCT02442063 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Bone Diseases

Interventions

DRUG: Radium Ra 223 dichloride (Xofigo, BAY88-8223)
DRUG: paclitaxel

Sponsor

Bayer